KWON, DAE YOUNG,권대영,SUNG, MI JEONG,성미정,HWANG, JIN TAEK,황진택,PARK, JAE HO,박재호,YANG, HYE JEONG,양혜정,HUR, HAEONG JEON,허행전,KIM, HYUN JIN,김현진,YOON, SUK HOO,윤석후,KIM, MYUNG SUNNY,김명선
申请号：
KR1020110037694
公开号：
KR1020120120516A
申请日:
2011.04.22
申请国别(地区):
KR
年份:
2012
代理人:
摘要：
PURPOSE: A pharmaceutical composition and a health functional food containing methyl caffeate for preventing and treating obesity and lipid related metabolic diseases are provided to suppress adipocyte differentiation.CONSTITUTION: A pharmaceutical composition for preventing and treating obesity and lipid related metabolis diseases contains methyl caffeate as an active ingredient. The methyl caffeate is n-octyl-3,4-dimethyl caffeate. The metabolic diseases are hyperlipidemia, fatty liver, arteriosclerosis, cardiovascular disease, or metabolic disease of combination thereof. The composition is a capsule, tablet, granule, powder, or beverage. A health functional food for preventing and relieving obesity and lipid related metabolic disease contains the metyl caffeate as an active ingredient. The health functional food is a capsule, tablet, granule,powder, or beverage.COPYRIGHT KIPO 2013[Reference numerals] (AA) Control group본 발명은 메틸 카페이트를 유효성분으로 함유하는 비만 및 지질 관련 대사성 질환의 예방 및 치료용 약학적 조성물과 건강기능식품에 관한 것이다. 상기 조성물 또는 건강기능식품은 지방세포분화 저해 효능이 우수하다.
